Works by Nishimura, Nobutaka


Results: 58
    1

    Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2025.102326
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iemura, Yusuke;
    • Yoshikawa, Motokiyo;
    • Torimoto, Kazumasa;
    • Tomioka, Atsushi;
    • Sakamoto, Keichi;
    • Matsumura, Yoshiaki;
    • Naoi, Makito;
    • Ichii, Daiki;
    • Inoue, Kuniaki;
    • Narita, Kosuke;
    • Oyama, Nobuo;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi
    Publication type:
    Article
    2

    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 329, doi. 10.1093/jjco/hyad170
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Ohmori, Chihiro;
    • Takamatsu, Norimi;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Matsumoto, Yoshihiro;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Okajima, Eijiro;
    • Masaomi, Kuwata;
    • Sakamoto, Keichi;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    3

    The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 192, doi. 10.1093/jjco/hyad155
    By:
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Miyake, Makito;
    • Miyata, Haruka;
    • Matsumoto, Ryuji;
    • Osawa, Takahiro;
    • Nishimura, Nobutaka;
    • Fujimoto, Kiyohide;
    • Inokuchi, Junichi;
    • Yoneyama, Takahiro;
    • Tomida, Ryotaro;
    • Numakura, Kazuyuki;
    • Matsushita, Yuto;
    • Matsumoto, Kazumasa;
    • Sato, Takuma;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka
    Publication type:
    Article
    4

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    5

    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 343, doi. 10.1093/jjco/hyac203
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    6

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    7
    8

    Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 841, doi. 10.3390/cancers16040841
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Yoshida, Takanori;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Oda, Yuki;
    • Kohashi, Mikiko;
    • Tomizawa, Mitsuru;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Dotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    9
    10

    Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.

    Published in:
    Cancers, 2023, v. 15, n. 7, p. 2002, doi. 10.3390/cancers15072002
    By:
    • Numakura, Kazuyuki;
    • Miyake, Makito;
    • Kobayashi, Mizuki;
    • Muto, Yumina;
    • Sekine, Yuya;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Shiga, Masanori;
    • Morizane, Shuichi;
    • Yoneyama, Takahiro;
    • Matsumura, Yoshiaki;
    • Abe, Takashige;
    • Yamada, Takeshi;
    • Matsumoto, Kazumasa;
    • Inokuchi, Junichi;
    • Nishiyama, Naotaka;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Kitamura, Hiroshi
    Publication type:
    Article
    11

    Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1735, doi. 10.3390/cancers14071735
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Fujii, Koyo;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Tomizawa, Mitsuru;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Kiba, Keisuke;
    • Tanaka, Masahiro;
    • Oyama, Nobuo;
    • Okajima, Eijiro;
    • Fujimoto, Ken;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    12

    Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2615, doi. 10.3390/cancers13112615
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Fujii, Tomomi;
    • Nishikawa, Ryoma;
    • Teraoka, Shogo;
    • Takenaka, Atsushi;
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Shinohara, Nobuo;
    • Okajima, Eijiro;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Tsuchiya, Norihiko;
    • Owari, Takuya;
    • Murakami, Yasukiyo;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Nishiyama, Naotaka
    Publication type:
    Article
    13
    14

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    15
    16
    17
    18
    19

    Differences in oncological benefits from second transurethral resection between white‐light initial surgery and photodynamic diagnosis‐guided initial surgery for primary high‐risk non‐muscle invasive bladder cancer.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 8, p. 876, doi. 10.1111/iju.15474
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nakahama, Tomonori;
    • Nishimoto, Koshiro;
    • Oyama, Masafumi;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fukuhara, Hideo;
    • Inoue, Keiji;
    • Kobayashi, Keita;
    • Matsuyama, Hideyasu;
    • Fujii, Tomomi;
    • Hirao, Yoshihiko;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    20

    Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 12, p. 1112, doi. 10.1111/iju.15283
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Nakahama, Tomonori;
    • Miyamoto, Tatsuki;
    • Nishimoto, Koshiro;
    • Oyama, Masafumi;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fukuhara, Hideo;
    • Inoue, Keiji;
    • Kobayashi, Keita;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Fujii, Tomomi;
    • Hirao, Yoshihiko;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    21
    22

    Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 5, p. 473, doi. 10.1111/iju.15162
    By:
    • Miyamoto, Tatsuki;
    • Miyake, Makito;
    • Nakahama, Tomonori;
    • Nishimura, Nobutaka;
    • Onishi, Kenta;
    • Iida, Kouta;
    • Yonemori, Masaya;
    • Enokida, Hideki;
    • Nakagawa, Masayuki;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fujii, Tomomi;
    • Shimada, Keiji;
    • Baba, Satoshi;
    • Kinjyo, Mitsuru;
    • Shimokama, Tatsuro;
    • Okumura, Koji;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    23
    24

    C‐reactive protein as a prognostic predictor for non‐muscle invasive bladder cancer after intravesical bacillus Calmette‐Guérin therapy: A Japan Urological Oncology Group study analysis.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 3, p. 299, doi. 10.1111/iju.15106
    By:
    • Nishikawa, Ryoma;
    • Miyake, Makito;
    • Morizane, Shuichi;
    • Shimizu, Ryutaro;
    • Teraoka, Shogo;
    • Honda, Masashi;
    • Iida, Kota;
    • Nishimura, Nobutaka;
    • Sazuka, Tomokazu;
    • Kimura, Takahiro;
    • Ito, Akihiro;
    • Shiga, Kenichiro;
    • Taoka, Rikiya;
    • Kojima, Takahiro;
    • Kobayashi, Takashi;
    • Nishiyama, Naotaka;
    • Kitamura, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide;
    • Takenaka, Atsushi
    Publication type:
    Article
    25

    Clinical significance of limited and extended pelvic lymph node dissection during robot‐assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 2, p. 168, doi. 10.1111/iju.15075
    By:
    • Hori, Shunta;
    • Nakai, Yasushi;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Yoneda, Tatsuo;
    • Fujimoto, Kiyohide;
    • Tanaka, Nobumichi
    Publication type:
    Article
    26

    Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer.

    Published in:
    International Journal of Urology, 2022, v. 29, n. 10, p. 1195, doi. 10.1111/iju.14976
    By:
    • Murakami, Yasukiyo;
    • Matsumoto, Kazumasa;
    • Miyake, Makito;
    • Amano, Noriyuki;
    • Shimura, Soichiro;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Matsushita, Yuto;
    • Abe, Takashige;
    • Yamada, Takeshi;
    • Uemura, Motohide;
    • Matsui, Yoshiyuki;
    • Taoka, Rikiya;
    • Kojima, Takahiro;
    • Kobayashi, Takashi;
    • Nishiyama, Naotaka;
    • Kitamura, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide;
    • Iwamura, Masatsugu
    Publication type:
    Article
    27
    28

    Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy.

    Published in:
    International Journal of Urology, 2022, v. 29, n. 3, p. 242, doi. 10.1111/iju.14759
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Iida, Kota;
    • Miyamoto, Tatsuki;
    • Tomida, Ryotaro;
    • Numakura, Kazuyuki;
    • Inokuchi, Junichi;
    • Yoneyama, Takahiro;
    • Matsumura, Yoshiaki;
    • Yajima, Shugo;
    • Masuda, Hitoshi;
    • Terada, Naoki;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka;
    • Kitamura, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    29
    30

    Clinical outcomes after intravesical bacillus Calmette–Guérin for the highest‐risk non‐muscle‐invasive bladder cancer newly defined in the Japanese Urological Association Guidelines 2019.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 7, p. 720, doi. 10.1111/iju.14545
    By:
    • Miyamoto, Tatsuki;
    • Miyake, Makito;
    • Toyoshima, Yuta;
    • Fujii, Tomomi;
    • Shimada, Keiji;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Nakahama, Tomonori;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Ohbayashi, Chiho;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    31
    32
    33

    Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1311, doi. 10.1007/s10147-024-02573-5
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Inoue, Kuniaki;
    • Tachibana, Akira;
    • Yoshikawa, Takanosuke;
    • Sakamoto, Keichi;
    • Ohnishi, Mikiko;
    • Maesaka, Fumisato;
    • Takamatsu, Norimi;
    • Mieda, Kosuke;
    • Ohmori, Chihiro;
    • Matsubara, Toshihiko;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    34

    Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 205, doi. 10.1007/s10147-023-02447-2
    By:
    • Matsushita, Yuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishimoto, Koshiro;
    • Fukuhara, Hideo;
    • Kobayashi, Keita;
    • Oyama, Masafumi;
    • Inoue, Keiji;
    • Matsuyama, Hideyasu;
    • Fujimoto, Kiyohide;
    • Miyake, Hideaki
    Publication type:
    Article
    35

    First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1733, doi. 10.1007/s10147-022-02230-9
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Matsubara, Toshihiko;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keichi;
    • Yamada, Atsushi;
    • Matsumoto, Yoshihiro;
    • Yoshikawa, Motokiyo;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Hosokawa, Yukinari;
    • Tanaka, Masahiro;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    36

    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6145, doi. 10.1007/s00520-022-07043-0
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Ohnishi, Sayuri;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    37

    Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 1, p. 887, doi. 10.1007/s00520-021-06468-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Yoneda, Tatsuo;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    38

    Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2025, v. 37, n. 2, p. 146, doi. 10.1080/1120009X.2024.2340885
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    39

    Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data

    Published in:
    Cancer Management & Research, 2022, v. 14, p. 623, doi. 10.2147/CMAR.S348899
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Shimizu, Takuto;
    • Ohnishi, Mikiko;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Inoue, Takeshi;
    • Ohnishi, Kenta;
    • Matsumoto, Yoshihiro;
    • Yoshida, Takanori;
    • Tatsumi, Yoshihiro;
    • Shinohara, Masatake;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi
    Publication type:
    Article
    40

    Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.

    Published in:
    World Journal of Surgical Oncology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12957-020-01872-1
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Aoki, Katsuya;
    • Ohmori, Chihiro;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    41

    Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.

    Published in:
    Oncology Letters, 2020, v. 20, n. 5, p. 1, doi. 10.3892/ol.2020.12052
    By:
    • MAKITO MIYAKE;
    • YUKI ODA;
    • NOBUTAKA NISHIMURA;
    • YOSUKE MORIZAWA;
    • SAYURI OHNISHI;
    • KINTA HATAKEYAMA;
    • TOMOMI FUJII;
    • SHUNTA HORI;
    • DAISUKE GOTOH;
    • YASUSHI NAKAI;
    • SATOSHI ANAI;
    • KAZUMASA TORIMOTO;
    • SHINJI TSUKAMOTO;
    • HIROMASA FUJII;
    • AKIRA KIDO;
    • KANYA HONOKI;
    • YOSHIAKI MATSUMURA;
    • EIJIRO OKAJIMA;
    • NOBUMICHI TANAKA;
    • KIYOHIDE FUJIMOTO
    Publication type:
    Article
    42
    43
    44
    45

    Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 196.e1, doi. 10.1016/j.clgc.2021.11.006
    By:
    • Makito Miyake;
    • Takuto Shimizu;
    • Nobutaka Nishimura;
    • Keisuke Kiba;
    • Fumisato Maesaka;
    • Yuki Oda;
    • Akira Tachibana;
    • Mitsuru Tomizawa;
    • Chihiro Ohmori;
    • Yoshiaki Matsumura;
    • Kazuki Ichikawa;
    • Shinichiro Mizobuchi;
    • Takanosuke Yoshikawa;
    • Shunta Hori;
    • Yosuke Morizawa;
    • Daisuke Gotoh;
    • Yasushi Nakai;
    • Satoshi Anai;
    • Kazumasa Torimoto;
    • Katsuya Aoki
    Publication type:
    Article
    46

    Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).

    Published in:
    2021
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Inoue, Takashi;
    • Suzuki, Shota;
    • Fujii, Tomomi;
    • Owari, Takuya;
    • Hori, Shunta;
    • Nakai, Yasushi;
    • Toritsuka, Michihiro;
    • Nakagawa, Hitoshi;
    • Tsukamoto, Shinji;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Yoneda, Tatsuo;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    journal article
    47

    Validation of non‐muscle‐invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines.

    Published in:
    BJUI Compass, 2024, v. 5, n. 2, p. 269, doi. 10.1002/bco2.305
    By:
    • Miyake, Makito;
    • Kitamura, Hiroshi;
    • Nishimura, Nobutaka;
    • Miyamoto, Tatsuki;
    • Nakahama, Tomonori;
    • Fujii, Tomomi;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Yonemori, Masaya;
    • Enokida, Hideki;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Matsui, Yoshiyuki;
    • Nishiyama, Naotaka;
    • Nishiyama, Hiroyuki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    48

    Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes.

    Published in:
    BJUI Compass, 2023, v. 4, n. 3, p. 305, doi. 10.1002/bco2.215
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nakahama, Tomonori;
    • Nishimoto, Koshiro;
    • Oyama, Masafumi;
    • Matsushita, Yuto;
    • Miyake, Hideaki;
    • Fukuhara, Hideo;
    • Inoue, Keiji;
    • Kobayashi, Keita;
    • Matsumoto, Hiroaki;
    • Matsuyama, Hideyasu;
    • Fujii, Tomomi;
    • Hirao, Yoshihiko;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    49
    50

    Comparison of Post‐Radical Cystectomy Renal Function and Ileal Conduit‐Related Complications Between Extracorporeal and Robot‐Assisted Intracorporeal Urinary Diversion: A Single‐Center Experience.

    Published in:
    Asian Journal of Endoscopic Surgery, 2025, v. 18, n. 1, p. 1, doi. 10.1111/ases.70033
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Iida, Kota;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Inoue, Takeshi;
    • Anai, Satoshi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article